Header Logo

Connection

ROHTESH S MEHTA to Leukemia, Myelomonocytic, Chronic

Back to Details
This is a "connection" page, showing publications ROHTESH S MEHTA has written about Leukemia, Myelomonocytic, Chronic.
ROHTESH S MEHTA
Connection Strength
0.037
Leukemia, Myelomonocytic, Chronic
  1. Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure. J Hematol Oncol. 2022 01 29; 15(1):12.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.